个人简历

教育背景： 2003.9-2007.6 四川大学华西药学院 理学学士（药学） 2007.9-2010.6 北京协和医学院理学硕士（药理学） 2010.9-2013.6北京协和医学院 医学博士（药理学） 工作经历： 2013.7-2015.6 北京协和医学院&苏州方舟基因药业 博士后（细胞生物学） 2015.7-2018.7 美国加州大学洛杉矶分校戴卫格芬医学院 博士后（分子免疫学） 2018.9-至今 北京化工大学生命科学与技术学院 副教授（生物医学工程）

研究领域

1.神经生长因子纳米胶囊用于康复医学的治疗 2.非人灵长类动物药物成瘾、抑郁模型的建立以及治疗药物的研究 3.仿生纳米材料组织渗透性的分子机制及靶向药物的研究 4.小分子化合物纳米新剂型的设计与制备

近期论文

1. Di Wu, Meng Qin(Co-first author), Duo Xu, Chaoyong Liu, Jie Ren, Chen Chen, Fengmei Yang, Yanyan Li, Yuan Zhao, Ruyi Huang, Chunsheng Kang, Masakazu Kamata, Irvin Chen, Zhanlong He*, Jing Wen*, Wei Chen*, and Yunfeng Lu*. A Bioinspired Platform for Effective Brain Delivery of Protein Therapeutics. Advanced Materials. 2019, 201807557.
2. Duo Xu, Di Wu, Meng Qin(Co-first author), Lina R. Nih, Chaoyong Liu, Jie Ren, Xiangjun Chen, Zhanlong He, Wenhai Yu, Jiaoqiong Guan, Suqin Duan, Fang Liu, Jesse Li, Dushawn Harley, Bin Xum, Irvin S.Y. Chen, Jing Wen*, Wei Chen*, Sina Pourtaheri*, and Yunfeng Lu*. Delivery of Neurotrophins to the Central Nervous System for Neural Regeneration. Advanced Materials. 2019, 201900727.
3. Meng Qin, Jing Wen, Lan Wang, Duo Xu, Yoojin Lee, Zhanlong He, Jiaoqiong Guan, Suqin Duan, Yun luo, Guibo Sun, Xiaobo Sun, Yunfeng Lu, Masakazu Kamata* and Irvin S.Y*. Chen. Hydrolysable nanocapsules improve the brain penetration of Rituximan in nonhuman primates. Molecular therapy, 2019, revised.
4. Jing Wen, Di Wu, Meng Qin, Chaoyong Liu, Duo Xu, Harry V. Vinters, Yang Liu, Emiko Kranz, YooJin Lee, Xin Guan, Guibo Sun, Xiaobo Sun, Otoniel Martinez-Maza, Daniel Widney, Yunfeng Lu, Irvin SY. Chen,* and Masakazu Kamata*. Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system. Nature Biomedical Engineering, (2018),10.1038
5. Meng Qin, Xin Guan, Yu Zhang, Bin Shen, Fang Liu, Qingyu Zhang, Yupo Ma and Yongping Jiang*. Evaluation of ex vivo produced endothelial progenitor cells for autologous transplantation in primates. Stem Cell Research & Therapy (2018) 9:14
6. Meng Qin, Xin Guan, Huihui Wang, Yu Zhang,Bin Shen, Qingyu Zhang, Wei Dai, Yupo Ma and Yongping Jiang*. An effective ex-vivo approach for inducing endothelial progenitor cells from umbilicalcord blood CD34+ cells. Stem Cell Research & Therapy (2017) 8:25
7. Meng Qin, Yun Luo, Shan Lu, Jing Sun, Ke Yang, Guibo Sun* and Xiaobo Sun*. Ginsenoside F1 Ameliorates Endothelial Cell Inflammatory Injury and Prevents Atherosclerosis in Mice through A20-Mediated Suppression of NF-kB Signaling. Front Pharmacol. (2017) 22; 8: 953.
8. Meng Qin, Yun Luo, Xiang-bao Meng, Min Wang, Hong-wei Wang, Shi-yu Song, Jing-xue Ye, Fan Yao, Ping Wu, Gui-bo Sun* and Xiao-bo Sun*. Myricitrin Attenuates Endothelial Cell Apoptosis to Prevent Atherosclerosis: an Insight into PI3K/Akt Activation and STAT3/HO-1 Pathways. Vascular Pharmacology, 70 (2015) 23-34